Fig. 4
From: LncRNA ENST00000539653 acts as an oncogenic factor via MAPK signalling in papillary thyroid cancer
Association of ENS-653 expression with BRAF (V600E) mutation and disease-free survival in TCGA PTC cohort. a Statistical analysis of ENS-653 expression between BRAF (V600E) mutation and wtBRAF PTC patients. Data are expressed with median (interquartile range). **P < 0.01. b Survival was analyzed and compared between patients with high and low levels of ENS-653 expression; n = 457, log-rank test